Cwm, LLC Cassava Sciences Inc Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Cwm, LLC holds 591 shares of SAVA stock, worth $1,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares

591

Previous 1,449 59.21%

Holding current value

$1,790

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$1.85 - $3.41 $1,587 - $2,925	-858 Reduced 59.21%	591 $2,000
Q2 2025 Jul 25, 2025	SELL	$1.19 - $2.24 $4,103 - $7,723	-3,448 Reduced 70.41%	1,449 $3,000
Q1 2025 May 01, 2025	BUY	$1.5 - $3.02 $6,619 - $13,327	4,413 Added 911.78%	4,897 $7,000
Q4 2024 Feb 04, 2025	BUY	$2.29 - $32.18 $421 - $5,921	184 Added 61.33%	484 $1,000
Q3 2024 Oct 08, 2024	BUY	$9.57 - $35.08 $95 - $350	10 Added 3.45%	300 $9,000
Q2 2024 Jul 09, 2024	BUY	$12.35 - $26.11 $370 - $783	30 Added 11.54%	290 $4,000
Q1 2024 Apr 05, 2024	BUY	$18.44 - $26.41 $4,794 - $6,866	260 New	260 $5,000
Q3 2023 Oct 11, 2023	SELL	$16.64 - $25.32 $4,392 - $6,684	-264 Reduced 94.96%	14 $0
Q1 2022 Apr 21, 2022	BUY	$32.6 - $53.05 $9,062 - $14,747	278 New	278 $10,000
Q4 2021 Jan 31, 2022	SELL	$36.77 - $90.91 $7,354 - $18,182	-200 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$6.79 - $12.25 $1,358 - $2,450	200 New	200 $17,000
Q4 2020 Jan 27, 2021	SELL	$6.79 - $12.25 $1,358 - $2,450	-200 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$2.86 - $11.51 $572 - $2,302	200 New	200 $17,000
Q3 2020 Oct 19, 2020	SELL	$2.86 - $11.51 $572 - $2,302	-200 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$2.04 - $9.64 $408 - $1,928	200 New	200 $17,000
Q2 2020 Jul 22, 2020	SELL	$2.04 - $9.64 $408 - $1,928	-200 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$3.26 - $9.65 $652 - $1,930	200 New	200 $17,000
Q1 2020 Apr 28, 2020	SELL	$3.26 - $9.65 $652 - $1,930	-200 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$1.1 - $6.12 $220 - $1,224	200 New	200 $17,000
Q4 2019 Jan 27, 2020	SELL	$1.1 - $6.12 $220 - $1,224	-200 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$1.04 - $1.45 $208 - $290	200 New	200 $17,000
Q3 2019 Oct 22, 2019	SELL	$1.04 - $1.45 $208 - $290	-200 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$1.02 - $1.34 $204 - $268	200 New	200 $17,000
Q2 2019 Jul 31, 2019	SELL	$1.02 - $1.34 $204 - $268	-200 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$0.92 - $1.29 $184 - $258	200 New	200 $0

Others Institutions Holding SAVA

# of Institutions

134

Shares Held

13.8M

Call Options Held

962K

Put Options Held

864K

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $121M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account